Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-of-1 Platform Validation: Caffeine vs L-theanine
NCT04056650Phase 4Terminated
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Oct 2019
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Percent of individuals who reach study completion up to 27 days. Started Oct 2019; status: terminated.
Beyond the preview
Go deeper on NCT04056650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04056650.